Establishing Sickle Cell Disease Stroke Prevention Teams in Africa is Feasible: Program Evaluation Using the RE-AIM Framework: Erratum

No authors listed

Published Erratum

No authors listed. J Pediatr Hematol Oncol. 2022.

. 2022 May 1;44(4):193.

doi: 10.1097/MPH.0000000000002471. Epub 2022 Apr 21.

No abstract available

Erratum for

Establishing Sickle Cell Disease Stroke Prevention Teams in Africa is Feasible: Program Evaluation Using the RE-AIM Framework.
Ghafuri DL, Abdullahi SU, Dambatta AH, Galadanci J, Tabari MA, Bello-Manga H, Idris N, Inuwa H, Tijjani A, Suleiman AA, Jibir BW, Gambo S, Gambo AI, Khalifa Y, Haliru L, Abdulrasheed S, Zakari MA, Greene BC, Trevathan E, Jordan LC, Aliyu MH, Baumann AA, DeBaun MR. Ghafuri DL, et al. J Pediatr Hematol Oncol. 2022 Jan 1;44(1):e56-e61. doi: 10.1097/MPH.0000000000002179. J Pediatr Hematol Oncol. 2022. PMID: 34001783 Free PMC article. Clinical Trial.

1. Ghafuri DL, Abdullahi SU, Dambatta AH, et al. Establishing sickle cell disease stroke prevention teams in Africa is feasible: program evaluation using the RE-AIM framework. J Pediatr Hematol Oncol. 2022;44:e56–e61. - PMC - PubMed